peptides
Ipamorelin
Ipamorelin is a selective growth hormone secretagogue pentapeptide studied for its high GHS-R1a receptor selectivity in in vitro research models.
In vitro research use only · Not for human or animal use
🚚 Fast Free Shipping on All Orders

5mg/5mg · Purity: ≥99% (individual components)
Select Size
A pre-combined research vial containing CJC-1295 (No DAC) and Ipamorelin for studies examining GHRH receptor and GHS-R1a receptor co-activation in in vitro models.
Notify me when back in stock
Ships from Florida · Dispatches within 24 hours
A pre-combined research vial containing CJC-1295 (No DAC) and Ipamorelin for studies examining GHRH receptor and GHS-R1a receptor co-activation in in vitro models.
This blend pairs CJC-1295 (No DAC), a GHRH analogue, with Ipamorelin, a selective GHS-R1a agonist. The combination is used in research examining the downstream effects of simultaneous GHRH receptor and growth hormone secretagogue receptor activation in cell-based assays. For qualified laboratory research only.
CJC-1295 (No DAC) + Ipamorelin (5mg/5mg) is supplied by Coastal Bio Labs as a research-grade compound for in vitro laboratory research use only. Not for human or animal use, diagnosis, or treatment.
Store lyophilized at −20 °C. Reconstitute with sterile bacteriostatic water under aseptic conditions. Use within 30 days when stored at 4 °C after reconstitution.
Handle per applicable laboratory safety protocols. This compound is for in vitro research only.
Purity: ≥99% (individual components)
COA: Available on request
Testing: Third-party laboratory verification
Free standard shipping on all orders. Orders dispatched within 1–2 business days in plain, discreet packaging.
All sales are final once shipped. See our Refund Policy for full details.
A pre-combined research vial containing CJC-1295 (No DAC) and Ipamorelin for studies examining GHRH receptor and GHS-R1a receptor co-activation in in vitro models.
This blend pairs CJC-1295 (No DAC), a GHRH analogue, with Ipamorelin, a selective GHS-R1a agonist. The combination is used in research examining the downstream effects of simultaneous GHRH receptor and growth hormone secretagogue receptor activation in cell-based assays. For qualified laboratory research only.
Coastal Bio Labs supplies CJC-1295 (No DAC) + Ipamorelin (5mg/5mg) at ≥99% (individual components) purity, independently verified by third-party HPLC testing. A Certificate of Analysis (COA) is available for every batch on request. It is a research-grade compound supplied strictly for research use only.
Store lyophilized at −20 °C. Reconstitute with sterile bacteriostatic water under aseptic conditions. Use within 30 days when stored at 4 °C after reconstitution.
CJC-1295 (No DAC) + Ipamorelin (5mg/5mg) is sold by Coastal Bio Labs strictly as a research-grade compound for in vitro laboratory research use only. It is not a drug, supplement, or medical product and is not approved for human or animal use, diagnosis, or treatment. Researchers are responsible for compliance with all applicable institutional, state, and federal regulations.
peptides
Ipamorelin is a selective growth hormone secretagogue pentapeptide studied for its high GHS-R1a receptor selectivity in in vitro research models.
In vitro research use only · Not for human or animal use
peptides
CJC-1295 without DAC (Drug Affinity Complex) is a modified GHRH analogue with a shorter half-life profile, studied in GH axis receptor binding research.
In vitro research use only · Not for human or animal use
peptides
Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous GHRH, studied in growth hormone axis research. High-purity lyophilized compound.
In vitro research use only · Not for human or animal use